Skip to main content
Livermore
Livermore
ZHEN

C4 Therapeutics, Inc.

CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001662579

No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding C4 Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CCCC: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders92106+14
Shares47.0M58.2M+11.2M (+23.9%)
Value$265.6M$475.6M+$210.0M (+79.1%)

New holders (39)

Institutions that held C4 Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to CCCC in Q1 2024
InstitutionSharesValue% of portfolio
Silverarc Capital Management, LLC1,435,931$11.7M3.29%
Two Sigma Investments, LP1,171,840$9.57M0.02%
Rafferty Asset Management, LLC833,681$6.81M0.03%
Laurion Capital Management LP535,342$4.37M0.12%
Atom Investors LP316,246$2.58M0.32%
Trexquant Investment LP224,487$1.83M0.04%
Wellington Management Group LLP197,109$1.61M0.00%
BIT Capital GmbH168,090$1.37M0.12%
Profund Advisors LLC126,250$1.03M0.04%
Jump Financial, LLC116,507$951.9K0.03%
Engineers Gate Manager LP104,367$852.7K0.02%
Capital Fund Management S.A.76,791$627.4K0.01%
Quest Partners LLC64,001$522.9K0.09%
Marathon Trading Investment Management LLC64,000$522.9K0.21%
Walleye Capital LLC52,304$427.3K0.00%
Susquehanna Fundamental Investments, LLC51,365$419.7K0.02%
Gsa Capital Partners LLP48,763$398.0K0.03%
Graham Capital Management, L.P.47,449$387.7K0.01%
Fox Run Management, L.L.C.41,732$340.9K0.07%
E Fund Management Co., Ltd.39,396$321.9K0.02%
Mirae Asset Global Investments Co., Ltd.41,445$259.9K0.00%
Deerfield Management Company, L.P. (Series C)28,590$233.6K0.00%
EntryPoint Capital, LLC28,516$233.0K0.21%
Farallon Capital Management, L.L.C.28,000$228.8K0.00%
Walleye Trading LLC24,794$202.6K0.00%
SG Americas Securities, LLC22,368$183.0K0.00%
Polymer Capital Management (HK) LTD21,906$179.0K0.05%
Caxton Associates LP21,002$171.6K0.01%
Stifel Financial Corp20,012$163.5K0.00%
LMR Partners LLP19,563$159.8K0.00%
Occudo Quantitative Strategies LP18,317$149.7K0.03%
Brevan Howard Capital Management LP15,526$126.8K0.01%
Entropy Technologies, LP15,391$125.7K0.01%
Quantbot Technologies LP10,300$84.2K0.00%
Pacer Advisors, Inc.3,929$32.1K0.00%
Aquatic Capital Management LLC1,400$11.4K0.00%
Cape Investment Advisory, Inc.100$8170.00%
US Bancorp39$3190.00%
Macquarie Group Ltd4,009$330.00%

Sold out (25)

Institutions that held C4 Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of CCCC in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
AQR Capital Management LLC148,610$839.6K
Schonfeld Strategic Advisors LLC102,379$578.4K
Raymond James & Associates100,984$570.6K
Jacobs Levy Equity Management, Inc100,370$567.1K
Bank of Montreal76,800$463.1K
683 Capital Management, LLC55,602$314.2K
B. Metzler seel. Sohn & Co. AG49,037$277.1K
Cornercap Investment Counsel Inc46,286$261.5K
HSBC Holdings PLC30,200$170.6K
Algert Global LLC27,960$158.0K
Cresset Asset Management, LLC25,000$141.3K
Lighthouse Investment Partners, LLC21,981$124.2K
XTX Topco Ltd21,203$119.8K
Bank of New York Mellon Corp20,682$116.9K
Y-Intercept (Hong Kong) Ltd18,823$106.3K
Mirabella Financial Services LLP18,400$104.0K
Prelude Capital Management, LLC17,749$100.3K
Boothbay Fund Management, LLC13,400$75.7K
Lazard Asset Management LLC12,375$69.0K
Sherbrooke Park Advisers LLC11,131$62.9K
Shay Capital LLC10,000$56.5K
FNY Investment Advisers, LLC8,800$49.0K
Headlands Technologies LLC6,880$38.9K
Point72 Asia (Singapore) Pte. Ltd.3,928$22.2K
Fairfield, Bush & Co.200$1.13K